Please provide your email address to receive an email when new articles are posted on . The FDA approved the biosimilar filgrastim-aafi, designed to promote white blood cell recovery among individuals ...
New York, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, ...
We studied 60 consecutive autologous PBSCTs of 54 pre-treated patients with haematological malignancies at the Medical University Graz, Austria from August 2002 to June 2004. During this period, ...
Review the side-effects of Filgrastim as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Gary Lyman, MD, MPH, an oncologist and hematologist, compares the uptake of filgrastim biosimlars with pegfilgrastim biosimilars. Gary Lyman, MD, MPH, is an oncologist, hematologist, and public health ...
Sandoz Filgrastim approved in all indications as the reference product Sandoz becomes first company to secure approval for two biosimilars in Japan Approval marks continued expansion of Sandoz' ...
New York, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback